I dont believe the FDA wants to be overwhelmed by administrative overhead by all the requests they are getting for Leronlimab as an EIND again. This is why I think they went ahead with it..There are a helluva lot of doctors now that know about the drug as well as doctors seeing results in cd12 . Even though it’s blinded , I am Sure they are seeing an upswing in Survival ratesa d probably demanding it now..